Researches under the auspices of the National Cancer Institute’s Early Detection Research Network Biomarker Discovery Lab believe they have found a way to detect early-stage asbestos-related pulmonary cancer. A new protein that is 80 percent effective at detecting stage I pleural mesothelioma is giving hope for early-detection and prompt treatment of this deadly disease.
Malignant Pleural Mesothelioma
Malignant pleural mesothelioma is an aggressive pulmonary cancer linked directly to asbestos exposure. Unfortunately, signs and symptoms of this disease may have traditionally taken 20 to 50 years to manifest. This means that by the time this cancer is detected, it is often far too late to save the victim’s life.
Currently, only ten to 15 percent of patients are diagnosed with malignant pleural mesothelioma in stage I. Sadly, unless detected in stage I, treatment is often incredibly invasive and equally unsuccessful. If you have been exposed to asbestos, talk to your doctor about new techniques for early-detection to help ensure your health well into the future.
If you or a loved one is suffering the consequences of asbestos exposure, you may have a right to seek compensation. Maryland asbestos lawyer Matthew Kiely can assess your case and help you determine if you can seek damages for medical expenses, lost wages, and personal pain and suffering.
If you have been exposed to asbestos, please contact the Law Offices of Brown| Kiely, LLP to schedule a free initial consultation today. our attorneys represents people in Maryland, Washington D.C., and throughout the United States.